Form
SCHEDULE 13D/A
Active or control-oriented beneficial ownership filing.
Form
Active or control-oriented beneficial ownership filing.
Ownership
Beneficial ownership of this reported class.
Shares
Shares beneficially owned as disclosed.
Event date
Date tied to the ownership event or amendment.
Accepted by SEC
EDGAR acceptance date.
Key filing fact
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares owned | Sole voting power | Shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| DAFNA Capital Management, LLC | 15% | 15,333,446 | 0 | 15,333,446 | /s/ Nathan Fischel | Chief Executive Officer | 0001389933 |
| Dr. Nathan Fischel | 15% | 15,628,395 | 294,949 | 15,333,446 | /s/ Nathan Fischel | Nathan Fischel | 0001389932 |
| Dr. Fariba Ghodsian | 15% | 15,333,446 | 0 | 15,333,446 | /s/ Fariba Ghodsian | Fariba Ghodsian | 0001733969 |
| DAFNA LifeScience, L.P. | 7.9% | 8,005,938 | 0 | 8,005,938 | /s/ Nathan Fischel | Chief Executive Officer of DAFNA Capital Management, LLC, general partner of DAFNA LifeScience, L.P. | |
| DAFNA LifeScience Select, L.P. | 7.3% | 7,327,508 | 0 | 7,327,508 | /s/ Nathan Fischel | Chief Executive Officer of DAFNA Capital Management, LLC, general partner of DAFNA LifeScience Select, L.P. |
CIK / CUSIP context first